Gene · 54363
Papers4,548
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,548
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prototissues: Assembly strategies, collective behaviors, and emerging applications. | Bioact Mater | 2026 | 41567986 | PubTator, text mining | PubMed |
| Metal-based nanomaterials achieve tumor treatment strategies by overcoming the blood-brain barrier of glioma and responding to the tumor microenvironment. | Mater Today Bio | 2026 | 41560814 | PubTator, text mining | PubMed |
| Nanomedical approaches to deplete intracellular glutathione in oncology. | Chem Sci | 2026 | 41550570 | PubTator, text mining | PubMed |
| Asymmetric double layer Janus hydrogels with programmed nitric oxide release for chronic diabetic wound healing. | J Colloid Interface Sci | 2026 | 41548468 | PubTator, text mining | PubMed |
| Flower-like FeMoO4 nanoparticles as a peroxidase mimic for sensitive colorimetric immunoassay of CEA. | Spectrochim Acta A Mol Biomol Spectrosc | 2026 | 41544328 | PubTator, text mining | PubMed |
| Self-Propelled Nanoreactors for Enhanced Cascade Catalytic Cancer Therapy through NIR-II Fluorescence Imaging-Guided Readministration. | ACS Nano | 2026 | 41543913 | PubTator, text mining | PubMed |
| Identification of modifiable plasma protein markers of cardiometabolic risk in children and adolescents with obesity. | Nat Commun | 2026 | 41535681 | PubTator, text mining | PubMed |
| Real-time fluorescence diagnosis guided glucose-triggered chemodynamic therapy for diabetic wounds using covalent organic framework@metal-organic framework cascade nanoreactor. | J Colloid Interface Sci | 2026 | 41534175 | PubTator, text mining | PubMed |
| Dextran-based stimuli-responsive hydrogels for smart dressings in wound healing. | J Mater Sci Mater Med | 2026 | 41528558 | PubTator, text mining | PubMed |
| Glucose oxidase-triggered cascade reaction in nanocomposite hydrogel for on-demand nitric oxide delivery and diabetic wound regeneration. | Int J Biol Macromol | 2026 | 41520977 | PubTator, text mining | PubMed |
| Spatiotemporal NO/O2-releasing cascade nanozyme microneedles enhance diabetic infected wound healing by modulating the immune microenvironment. | Theranostics | 2026 | 41510153 | PubTator, text mining | PubMed |
| Glucose oxidase-powered nanocatalytic medicine: Rewiring tumor metabolism for multimodal cancer therapy. | Mater Today Bio | 2026 | 41509977 | PubTator, text mining | PubMed |
| Engineering Metallic Implants with Self-Catalytic Degradable Bionanozyme Coating and Ion-Releasing Biointerface for Bioadaptive Anti-infective and Osteogenic Functionality. | ACS Appl Mater Interfaces | 2026 | 41506512 | PubTator, text mining | PubMed |
| Spatiotemporal Organization of Nanoreactors in Artificial Cells by Liquid-Liquid Phase Separation for Regulation of Cascade Enzymatic Reactions. | Small | 2026 | 41503940 | PubTator, text mining | PubMed |
| Wireless nanopore electrodes (WNEs): from a non-contact conductive tip to applications in electroanalysis and electrocatalysis. | Chem Sci | 2026 | 41497179 | PubTator, text mining | PubMed |
| Stimuli-Responsive Nanozyme Reprograms Tumor Immunometabolism and Overcomes Therapeutic Resistance in Hepatocellular Carcinoma. | ACS Nano | 2026 | 41493269 | PubTator, text mining | PubMed |
| "Near-zero background signal" sensing platform for tumor marker based on catalytic amplification strategy in chronocoulometry. | Talanta | 2026 | 41490353 | PubTator, text mining | PubMed |
| A Dual-Metabolic Strategy Combining pH-Responsive Vascular Embolization and Localized Glucose Oxidase Delivery for Cascade Starvation Therapy of Tumor. | Biomacromolecules | 2026 | 41490079 | PubTator, text mining | PubMed |
| Nanodelivery Vectors Veiled in Natural Killer Cell Membranes: Enhancing Colorectal Cancer Therapy through Synergistic Starvation and Chemotherapy. | ACS Appl Mater Interfaces | 2026 | 41489079 | PubTator, text mining | PubMed |
| Fuel-Powered Soft Actuators: Emerging Strategies for Autonomous and Miniaturized Robots. | Nanomicro Lett | 2026 | 41484647 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54363/papers?page=10